Sponsorship of oncology clinical trials in the United States according to age of eligibility.
Dylan V NeelDavid S ShulmanClement MaFlorence BourgeoisSteven G DuBoisPublished in: Cancer medicine (2020)
Interventional oncology trials that include patients < 18 years are less likely to be industry-sponsored compared to oncology trials exclusively in patients ≥ 18 years. Compared to other medical disciplines, a smaller proportion of industry-sponsored oncology trials included patients < 18 years. Trial sponsorship is associated with differential trial characteristics, such as trial duration and number of patients enrolled, regardless of age.